ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
◂ Last issue Next issue ▸ Archive Cover PDF
Volume 13 (13); 2022
Editorial Commentary
The most effective but largely ignored target for prostate cancer early detection and intervention
Yan-gao Man, Ciaran Mannion, Anahid Jewett, Yi-Hsuan Hsiao, Aijun Liu, Andrzej Semczuk, Paul Zarogoulidis, Andrei B. Gapeev, Alessia Cimadamore, Peng Lee, Antonio Lopez-Beltran, Rodolfo Montironi, Francesco Massari, Xin Lu, Liang Cheng
J. Cancer 2022; 13(13): 3463-3475. doi:10.7150/jca.72973
Full text
PDF PubMed
PMC
Research Papers
Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea
Seung-Hoon Beom, Ki Beom Bae, Dae Young Zang, Joohee Bae, In Gyu Hwang, Hye Jin Kang, In Sook Woo, Byoung Yong Shim, Byung-Noe Bae, Jaekyung Cheon, Sang-Bo Oh, Joong-Bae Ahn
J. Cancer 2022; 13(13): 3396-3403. doi:10.7150/jca.74107
Full text
PDF PubMed
PMC
Early detection of colorectal cancer somatic mutations using cfDNA liquid biopsies in a murine carcinogenesis model
Héctor Martínez-Gregorio, Clara Díaz-Velásquez, Mario Esaú Romero-Piña, Miguel Ruiz de la Cruz, Norma Laura Delgado-Buenrostro, Aldo de la Cruz-Montoya, Yolanda Irasema Chirino, Luis Ignacio Terrazas, Luis Alberto Medina, Felipe Vaca-Paniagua
J. Cancer 2022; 13(13): 3404-3414. doi:10.7150/jca.76516
Full text
PDF PubMed
PMC
Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP
Weichao Dan, Yizeng Fan, Tao Hou, Yi Wei, Bo Liu, Taotao Que, Bixin Yu, Jin Zeng, Lei Li
J. Cancer 2022; 13(13): 3415-3426. doi:10.7150/jca.63514
Full text
PDF PubMed
PMC
Oncologic Benefit of Adjuvant Therapy in Lateral Pelvic Lymph Node Metastasis following Neoadjuvant Chemoradiotherapy and Lateral Pelvic Lymph Node Dissection
Yu-Juan Jiang, Si-Cheng Zhou, Jing-Hua Chen, Jian-Wei Liang
J. Cancer 2022; 13(13): 3427-3433. doi:10.7150/jca.77689
Full text
PDF PubMed
PMC
Risk factors of secondary cancer in nasopharyngeal carcinoma patients after radiotherapy
Wen-Jie Wang, Miao Li, Xin-Bin Pan
J. Cancer 2022; 13(13): 3452-3462. doi:10.7150/jca.77768
Full text
PDF PubMed
PMC
Prognostic Impact of Ectopic Fat Deposition within Psoas Muscle in Stage IV Gastric Cancer Patients Undergoing Systemic Chemotherapy
Takako Ikegami, Hiroki Nishikawa, Masahiro Goto, Fukutaro Shimamoto, Tetsuji Terazawa, Toshifumi Yamaguchi, Eiki Yamasaki, Ken Asaishi, Shiro Nakamura, Kazuhide Higuchi
J. Cancer 2022; 13(13): 3477-3484. doi:10.7150/jca.78407
Full text
PDF PubMed
PMC
What Causes Death in Esophageal Cancer Patients Other Than the Cancer Itself: A Large Population-Based Analysis
Xueer Zheng, Anlai Zhang, Yao Xiao, Kaibo Guo, Leitao Sun, Shanming Ruan, Fang Fang
J. Cancer 2022; 13(13): 3485-3494. doi:10.7150/jca.78004
Full text
PDF PubMed
PMC
Reviews
Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer
Zihan Quan, Yang Yang, Hongmei Zheng, Yuting Zhan, Jiadi Luo, Yue Ning, Songqing Fan
J. Cancer 2022; 13(13): 3434-3443. doi:10.7150/jca.77619
Full text
PDF PubMed
PMC
The pros and cons of the PCC staging system to guide surgical resectability and prognosis
Pei Liu, Yinghui Song, Kashif shakoor, Chuang Peng, Sulai Liu
J. Cancer 2022; 13(13): 3444-3451. doi:10.7150/jca.76696
Full text
PDF PubMed
PMC